Matches in Wikidata for { <http://www.wikidata.org/entity/Q73135212> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q73135212 description "article scientifique publié en septembre 2000" @default.
- Q73135212 description "artículu científicu espublizáu en setiembre de 2000" @default.
- Q73135212 description "im September 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73135212 description "scientific article published on 01 September 2000" @default.
- Q73135212 description "wetenschappelijk artikel" @default.
- Q73135212 description "наукова стаття, опублікована у вересні 2000" @default.
- Q73135212 name "Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trial" @default.
- Q73135212 name "Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trial" @default.
- Q73135212 type Item @default.
- Q73135212 label "Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trial" @default.
- Q73135212 label "Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trial" @default.
- Q73135212 prefLabel "Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trial" @default.
- Q73135212 prefLabel "Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trial" @default.
- Q73135212 P1433 Q73135212-AFC1AA74-83B9-4179-8B95-A9E1563CE60C @default.
- Q73135212 P1476 Q73135212-20D26AA8-951B-4165-A2C8-EEDEAEFBB989 @default.
- Q73135212 P2093 Q73135212-27F2D9F6-FA5B-4706-81B5-15051126E0C7 @default.
- Q73135212 P2093 Q73135212-3127B7B7-B7DA-4A7A-A245-D103C0D5AB5F @default.
- Q73135212 P2093 Q73135212-61F23C00-66BC-4E01-9FF3-3932ACE8B6BE @default.
- Q73135212 P2093 Q73135212-668D24D0-63F8-4704-9E2B-E91F2D91CD90 @default.
- Q73135212 P2093 Q73135212-68D692A4-EF9B-4E41-A424-29D60D86DF3C @default.
- Q73135212 P2093 Q73135212-69070E8F-D55F-4E66-A6EF-C11CD04413A4 @default.
- Q73135212 P2093 Q73135212-AD465888-2784-4F7B-9144-3697852FE4B1 @default.
- Q73135212 P2093 Q73135212-AEC5B412-CF07-4910-910A-D09749AC835A @default.
- Q73135212 P2093 Q73135212-B358A9A8-53D7-4659-BEA9-266739D05A4F @default.
- Q73135212 P2093 Q73135212-B81197E4-DC5F-40AF-A4FA-8F996F411E98 @default.
- Q73135212 P2093 Q73135212-DB7EACB8-B646-4FDD-989A-FBC34D01CACA @default.
- Q73135212 P2860 Q73135212-4B2AC428-0851-406F-A504-E7822F8AEE63 @default.
- Q73135212 P2860 Q73135212-8695BBA0-3C3F-4144-97A1-2B41725CDCFE @default.
- Q73135212 P2860 Q73135212-BD9D3BB7-50D9-4945-B6D8-791BBDC6D3C1 @default.
- Q73135212 P304 Q73135212-B7601EDB-2B94-4B2A-97CC-7D24D4E7C32C @default.
- Q73135212 P31 Q73135212-EFC48A1B-0659-482A-BCF6-5F45E1B6E505 @default.
- Q73135212 P356 Q73135212-21FBBC28-C5EE-4EE5-9690-D92A0E64E4AA @default.
- Q73135212 P478 Q73135212-6D09540A-F550-43BE-9AD6-4F294BF8AEBB @default.
- Q73135212 P577 Q73135212-20EBBD87-E0D7-4099-951C-26D1973A0EE6 @default.
- Q73135212 P698 Q73135212-8D494200-1ECB-4B17-9D98-43B5AF05392F @default.
- Q73135212 P921 Q73135212-F115D4A8-22C6-4E5D-9567-188007BA6C0D @default.
- Q73135212 P921 Q73135212-FCA4FEB0-20A6-4D6B-BD9D-72C14F86C519 @default.
- Q73135212 P356 S0959-8049(00)00240-9 @default.
- Q73135212 P698 11056333 @default.
- Q73135212 P1433 Q332260 @default.
- Q73135212 P1476 "Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trial" @default.
- Q73135212 P2093 "A Polli" @default.
- Q73135212 P2093 "C Fowst" @default.
- Q73135212 P2093 "E Bajetta" @default.
- Q73135212 P2093 "E Di Salle" @default.
- Q73135212 P2093 "G Massimini" @default.
- Q73135212 P2093 "G Piscitelli" @default.
- Q73135212 P2093 "J Cervek" @default.
- Q73135212 P2093 "L E Fein" @default.
- Q73135212 P2093 "L Y Dirix" @default.
- Q73135212 P2093 "M Kaufmann" @default.
- Q73135212 P2093 "S E Jones" @default.
- Q73135212 P2860 Q32020808 @default.
- Q73135212 P2860 Q74195354 @default.
- Q73135212 P2860 Q77124843 @default.
- Q73135212 P304 "S86-7" @default.
- Q73135212 P31 Q13442814 @default.
- Q73135212 P356 "10.1016/S0959-8049(00)00240-9" @default.
- Q73135212 P478 "36 Suppl 4" @default.
- Q73135212 P577 "2000-09-01T00:00:00Z" @default.
- Q73135212 P698 "11056333" @default.
- Q73135212 P921 Q412178 @default.
- Q73135212 P921 Q42824827 @default.